|25.89||+0.5300||+2.09%||Vol 156.60K||1Y Perf -61.03%|
|May 17th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||36.33||Analyst Rating||Moderate Buy 2.40|
|Potential %||40.32||Finscreener Ranking||★★★★ 52.56|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★+ 61.36|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★ 46.32|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||5.65||Earnings Rating||Strong Buy|
|Market Cap||591.20M||Earnings Date||5th May 2022|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.47|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||188.88K|
|Avg. Monthly Volume||200.06K|
|Avg. Quarterly Volume||174.83K|
Inogen Inc (NASDAQ: INGN) stock closed at 25.89 per share at the end of the most recent trading day (a 2.09% change compared to the prior day closing price) with a volume of 156.60K shares and market capitalization of 591.20M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 938 people. Inogen Inc CEO is Scott Wilkinson.
The one-year performance of Inogen Inc stock is -61.03%, while year-to-date (YTD) performance is -23.85%. INGN stock has a five-year performance of -68.31%. Its 52-week range is between 22.51 and 82.35, which gives INGN stock a 52-week price range ratio of 5.65%
Inogen Inc currently has a PE ratio of -28.70, a price-to-book (PB) ratio of 1.61, a price-to-sale (PS) ratio of 1.65, a price to cashflow ratio of 214.00, a PEG ratio of 2.32, a ROA of -4.29%, a ROC of -5.24% and a ROE of -5.70%. The company’s profit margin is -5.76%, its EBITDA margin is 5.70%, and its revenue ttm is $351.46 Million , which makes it $15.39 revenue per share.
Of the last four earnings reports from Inogen Inc, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.47 for the next earnings report. Inogen Inc’s next earnings report date is -.
The consensus rating of Wall Street analysts for Inogen Inc is Moderate Buy (2.4), with a target price of $36.33, which is +40.32% compared to the current price. The earnings rating for Inogen Inc stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Inogen Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Inogen Inc has a Neutral technical analysis rating based on Technical Indicators (ADX : 13.41, ATR14 : 1.37, CCI20 : 19.56, Chaikin Money Flow : -0.04, MACD : -1.33, Money Flow Index : 46.59, ROC : 2.41, RSI : 46.61, STOCH (14,3) : 82.84, STOCH RSI : 1.00, UO : 49.41, Williams %R : -17.16), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Inogen Inc in the last 12-months were: Alison Bauerlein (Option Excercise at a value of $742 435), Alison Bauerlein (Sold 19 264 shares of value $1 493 703 ), Bart Sanford (Option Excercise at a value of $0), Benjamin M. Anderson-Ray (Sold 4 516 shares of value $156 619 ), Brenton Taylor (Option Excercise at a value of $316 570), Brenton Taylor (Sold 7 942 shares of value $595 808 ), Loren L. Mcfarland (Option Excercise at a value of $17 435), Nabil Shabshab (Option Excercise at a value of $0), Raymond O. Huggenberger (Option Excercise at a value of $716 613), Raymond O. Huggenberger (Sold 24 681 shares of value $1 522 417 )
Tue, 11 Jan 2022 15:24 GMT Inogen (INGN) Receives a Hold from Leerink Partners- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.